Outsourcing of intermediates, APIs, and drug products has become an essential and strategic practice for many pharmaceutical manufacturers. As a trusted contract manufacturer of APIs and key intermediates, Juzen Chemical leverages its extensive experience and technical expertise to meet the diverse needs of our customers at every stage — from new drug development to the production of existing medicines. Business Fields: Oligonucleotide CDMO Services: Juzen Chemical offers comprehensive solutions for the development and manufacturing of nucleic acid pharmaceuticals. We provide flexible and reliable support tailored to customer needs, covering everything from laboratory-scale sample synthesis to manufacturing process development and GMP-compliant production. To further enhance production efficiency, Juzen Chemical has adopted the Contichrom® continuous purification chromatography system, enabling the high-quality production of nucleic acid oligomers. In addition, we have the capability to develop and manufacture novel modified nucleic acid monomers, allowing for seamless, end-to-end production from monomer synthesis to oligomer manufacturing. This integrated approach ensures smooth transitions across all stages of drug development and commercial production, delivering optimal solutions and high productivity to our customers. Small Molecule CDMO Services: At our Toyama site, Juzen Chemical provides contract manufacturing services for active pharmaceutical ingredients (APIs) and intermediates. Our facilities are equipped with a wide range of manufacturing systems capable of handling production volumes from gram scale to ton scale, supporting every stage from clinical trials to commercial supply. This comprehensive capability ensures a seamless and efficient contract manufacturing process. Leveraging our extensive manufacturing expertise, we have established a highly flexible system capable of managing complex processes. We specialize in ultra-low temperature reactions, high-temperature reactions, and hydrogenation reactions, achieving stable production even at ton-scale volumes. In addition, we have developed a robust quality control system aligned with global standards, operating under GMP guidelines in compliance with the United States Pharmacopeia (USP), Japanese Pharmacopoeia (JP), and European Pharmacopoeia (EP). This enables us to consistently deliver highly reliable products that meet and exceed our customers’ expectations. CMC Solution Services: To accelerate drug development, Juzen Chemical offers a comprehensive One-Stop CMC Solution Service across two locations: our Toyama site and the Shonan site, located within the Shonan Health Innovation Park. Through this integrated approach, we provide end-to-end support across all development stages, including manufacturing process studies, analytical method development, and optimization of scale-up processes for mid- to late-stage projects. Our services ensure compliance with regulatory standards such as the ICH Q3 series and facilitate the acquisition of data required for regulatory submissions. Backed by a team of experienced chemists, we deliver tailored, professional support to meet the specific needs of each project, responding swiftly and effectively to drive project success.
Jubilant Biosys
Jubilant Biosys Limited has over 20 years of experience in delivering Integrated Drug Discovery (IDD) and GMP development and manufacturing. Serving the global pharma industry, Jubilant Biosys employs over 2,400 people operating from five sites in India, with a presence in the USA, Europe, and Japan. The company is recognized in the industry for its scientific innovation, problem-solving mindset, and unwavering attention to customers’ needs. Jubilant Biosys has evolved as a leading CRDMO (Contract Research, Development, and Manufacturing Organization) partner in science, offering a full spectrum of services in drug discovery, development, and manufacturing. With the addition of biologics such as ADCs (Antibody-Drug Conjugates), mAbs (Monoclonal Antibodies) and large molecules like oligonucleotides, and peptides, the company has grown into an integrated entity, delivering end-to-end solutions from early discovery phases—including biology, medicinal chemistry, DMPK (Drug Metabolism and Pharmacokinetics), and toxicology—to chemical development and manufacturing of GMP (Good Manufacturing Practice) intermediates and APIs (Active Pharmaceutical Ingredients) for both clinical and commercial supplies. Biosys has consolidated advances in drug discovery by utilizing the latest AI/ML technologies and by incorporation of environment-friendly processes. This enables Biosys to partner with leading companies on the most challenging, cost and time-sensitive drug discovery and development programs. With a strong commitment to new technologies, supply chain, Quality, and ESG considerations, Biosys is a leading CRDMO partner for Big Pharma companies and Biotech.
Jubilant HollisterStier
Jubilant HollisterStier (JHS) CMO provides comprehensive sterile fill-finish and lyophilization services, ensuring the consistent delivery of high-quality products that meet the needs of global healthcare markets and patients worldwide. With our decades of experience and dual sites in Spokane and Montréal, we offer a flexible and collaborative partnership model for manufacturing excellence that enables our clients to increase speed to market with full regulatory confidence.
JOINN Laboratories (Suzhou) Co., Ltd.
JOINN Laboratories致力于提供药物研发CRO外包服务。 JOINN建立了符合国际标准的全面质量管理体系：CNAS/ILAC-MRA认证，NMPA，美国FDA，OECD，日本PMDA和韩国MFDS GLP认证以及国际AAALAC认证。 JOINN为申办者在非临床安全性评估、临床试验、注册和药物警戒方面的特定需求提供定制服务，涵盖从开发到最终药物注册的整个范围。 JOINN Laboratories致力于提供药物研发CRO外包服务。 JOINN建立了符合国际标准的全面质量管理体系：CNAS/ILAC-MRA认证，NMPA，美国FDA，OECD，日本PMDA和韩国MFDS GLP认证以及国际AAALAC认证。 JOINN为申办者在非临床安全性评估、临床试验、注册和药物警戒方面的特定需求提供定制服务，涵盖从开发到最终药物注册的整个范围。 | Biomere is a non-GLP preclinical in-vivo CRO located in Worcester, MA. We are owned by JOINN Laboaratories of China. We have been in existence for several decades supporting in-vivo discovery efficacy, PK/PD, and biodistirbution studies in rodents, rabbits, pigs, and NHP’s in all disease indications for all modalities of drug technologies, gene and cell therapy, and biologics.
JIANGSU YAOHAI BIO-PHARMACEUTICAL Co. ,Ltd
Yaohai Biopharmaceutical Co., Ltd. was founded in August 2010. It has served as a Microbial CRDMO (Contract Research, Development, and Manufacturing Organization) specializing in microbial expression systems and offering one-stop services, including microbial strain engineering, microbial cell banking, process development, pilot scale-up, cGMP-guided manufacturing, fill and finish, analysis and testing, etc. Since its establishment, we have been focusing on “VLP vaccine, peptide, cytokine, nano-antibody, enzyme, plasmid DNA, mRNA, and others recombinant proteins or nucleic acids” as vaccines or therapeutics for human, veterinary, and pet health management. | Yaohai Bio-Pharma, founded in August 2010, is a specialized Microbial CRDMO (Contract Research, Development, and Manufacturing Organization) offering end-to-end services based on microbial expression systems. Our integrated solutions span strain engineering, cell banking, process development, cGMP manufacturing, analytical testing, fill-finish, and regulatory support. We focus on recombinant protein/peptide, nano-body, mRNA, plasmid DNA, VLP vaccines and other modalities for both human and veterinary use. Core Strengths: 1. Comprehensive Service Platform: Covering the full development cycle—from preclinical to commercial production—under global regulatory standards (NMPA, FDA, EMA). 2. Advanced Manufacturing Capacity: 5 drug substance lines with a total microbial fermentation capacity of 7,500L (2L–2,000L), plus 2 drug product workshops for sterile fill-finish of vials (liquid/lyophilized powder) and pre-filled syringes/cartridges. 3. Scalable Solutions: Supporting rapid scale-up with GMP-compliant facilities and fermentors ranging from 2L to 2,000L. 4. Proven Expertise: A seasoned team with 15+ years of experience, delivering over 200 successful projects across diverse therapeutic areas.
Iwata Label USA
We provide and develop the functional labels and labeling machine for pharmaceuticals to protect drug contents(light protect, vial breakage) and keep safety for all medical workers. | Iwata Label USA, Inc. is involved with every facet of pharmaceutical labels and labeling, from planning, printing, and processing to the planning, design, assembly, and calibration of tack labelers (labeling machines) and after sales services. We are a division of the Japanese based IL Group which was founded in 1962 to expand business not only in Japan but overseas as well in the pharmaceutical tack label business. Our US office was established in 2018 to introduce our technologies and support US as well as other regionally based pharmaceutical companies with tack labeling and packaging sol | Bringing decades of pharmaceutical packaging experience and technology directly from Japan to the United States. | Iwata Label USA, Inc. is involved with every facet of pharmaceutical labels and labeling, from planning, printing, and processing to the planning, design, assembly, and calibration of tack labelers (labeling machines) and after sales services. We are a division of the Japanese based IL Group which was founded in 1962 to expand business not only in Japan but overseas as well in the pharmaceutical tack label business. Our US office was established in 2018 to introduce our technologies and support US as well as other regionally based pharmaceutical companies with tack labeling and packaging solutions. We are continuing to grow as an office and are looking forward to making an impact in the advancement of pharmaceutical packaging innovations and solutions in the US as well as potentially other countries in the region. Please contact us regarding any questions or requests you may have!
ITALIAN TRADE AGENCY
The Italian Trade Agency (ITA), in collaboration with ANFIA (Italian Association of the Automotive Industry) and Autopromotec / AICA (Italian Garage Equipment Manufacturers Association), proudly announces Italy’s dynamic presence at the 2025 AAPEX Show. Representing the heart of Italian excellence in automotive components and garage equipment, the delegation highlights the nation’s ongoing role as a global benchmark in technology, quality, and performance. Visitors can explore the Italian Pavilion at Booth A1061 (Level 2) in the International section, where eight Italian companies will showcase their latest technologies: • DETA Batteries • Errecom • FIAMM • Lopigom • M.E.A.T. & D.O.RI.A. • Metelli – GRAF • Osvat • Vantage Cast Europe | ITA – Italian Trade Agency is the Governmental agency that supports the business development of our companies abroad and promotes the attraction of foreign investment in Italy. The Italian Trade Agency, via its Machines Italia project promotes Italian industrial technology and innovation in partnership with fifteen Italian Machinery-Manufacturing Associations Representing Over 10,000+ Companies,ITA – Italian Trade Agency is the Governmental agency that supports the business development of our companies abroad and promotes the attraction of foreign investment in Italy. The Italian Trade Agency, via its Machines Italia project promotes Italian industrial technology and innovation in partnership with fifteen Italian Machinery-Manufacturing Associations Representing Over 10,000+ Companies | ITA – Italian Trade Agency is the Governmental agency that supports the business development of our companies abroad and promotes the attraction of foreign investment in Italy, through “Invest in Italy”, a project operated with Invitalia. With a motivated and modern organization and a global network of 79 offices in 65 countries, 5 of which are in the USA (New York, Los Angeles, Chicago, Huston and Miami) ITA provides information, assistance, consulting, promotion, and training to Italian small and medium-sized businesses in the industrial, consumer goods, and services sectors. Using the most modern multi-channel promotion and communication tools, it acts to assert the excellence of Made in Italy in the world. Every year, ITA worldwide offices carry out hundreds of promotional projects and provide personalized services and assistance to thousands of Italian companies. The Italian Trade Agency also assists and supports foreign companies that want to establish or expand business and trade relations with Italian companies or invest in Italy. The Italian Trade Agency collaborates with Italian Regions, Chambers of Commerce, Industry and Trade Associations, and other public and private organizations. | ITA – Italian Trade Agency is the Governmental agency that supports the business development of our companies abroad and promotes the attraction of foreign investment in Italy, through “Invest in Italy”, a project operated with Invitalia. With a motivated and modern organization and a global network of 87 offices in 74 countries, ITA provides information, assistance, consulting, promotion and training to Italian small and medium-sized businesses in the industrial, consumer goods and services sectors. Using the most modern multi-channel promotion and communication tools, it acts to assert the excellence of Made in Italy in the world. Every year, ITA worldwide offices carry outhundreds of promotional projects and provide personalized services and assistance to thousands of Italian companies. The Italian Trade Agency also assists and supports foreign companies that want to establish or expand business and trade relations with Italian companies or to invest in Italy. The Italian Trade Agency collaborates with Italian Regions, Chambers of Commerce, Industry and Trade Associations and other public and private organizations. | ITA – Italian Trade Agency is the Governmental agency that supports the business development of our companies abroad and promotes the attraction of foreign investment in Italy. With a motivated and modern organization and a widespread network of overseas offices, ITA provides information, assistance, consulting, promotion and training to Italian small and medium-sized businesses. Using the most modern multi-channel promotion and communication tools, it acts to assert the excellence of Made in Italy in the world. | ITA – Italian Trade Agency is the Governmental agency that supports the business development of our companies abroad and promotes the attraction of foreign investment in Italy. Using the most modern multi-channel promotion and communication tools, it acts to assert the excellence of Made in Italy in the world. | ITA – Italian Trade Agency is the Government entity supporting the internationalization of Italian enterprises and promoting foreign investment in Italy. Through a global network and advanced communication tools, it provides strategic assistance to SMEs, enhancing the prestige of Made in Italy worldwide. | The Italian Trade Agency (ITA) – the Italian Government Agency supporting Italian companies’ business development abroad and the attraction of foreign investment in Italy, provides information, assistance, consulting, promotion and training services. The Agency reaches out to thousands of US companies and other organizations every year, and the Chicago Office is part of a five office network within the US, supporting many of Italy’s manufacturing machinery sectors, including packaging.Italy is undeniably a world leader of packaging technologies and a hub for innovation, with Italian packaging machinery and materials suppliers offering a wide range of advanced solutions.Italian companies offer some of the most versatile and technologically advanced machines on the market, including customized solutions, providing customers with a unique competitive edge.The Italy pavilion at booth LU-8538 at Pack Expo 2024 will include these leading 18 Italian packaging suppliers.Come see us and explore how Italy can help you expand and move your business forward.ALIMEC SrlMINIPAN SrlBOTTA ECOPACKAGING SrlCROCCO SpADIPRAN ECOPACK SpAGHEZZI & ANNONI SrlGORRERI SrlIMETA SrlITP – INDUSTRIA TERMOPLASTICA PAVESE SpAL.M. SpAPACKINT Chocolate Machines SrlRICCIARELLI SpATECHNOWRAPP SrlTECNO POOL SpATECNOVAP SrlTORQ PACKAGING SrlUNIFILL | The ITA â Italian Trade Agency is an Italian government marketing agency that bridges Italian businesses with international markets and promotes the excellence of the “Made in Italy” brand globally.Italian Packaging OEMs are transforming North American industry challenges into cutting-edge, customized solutions.When you buy Italian equipment you’re entering into a partnership with the world’s most highly skilled engineers and manufacturers. The result is a smarter approach which combines sophisticated technology, flexible and customized solutions, and competitive pricing.Visit the ITALIA Pavilion at SU-32069 and explore how we can help expand and move your business forward with these industry leaders: Agripak, Bellini & Meda, CTI, Foodtech, Ecopack, Erre Enne, Europool, FMT, Innova, IPI, Itatools, Opto Engineering, Packint Chocolate Machines, Pasta Technologies Group, Ricciarelli, Technowrapp, Tecnopool, TMG Impianti, Zanasi, Zancaner. | The Italian Trade Agency (ITA), established in 1906, bridges Italian businesses with international markets. Our Houston office exemplifies this mission by focusing on and overseeing economic and business development activities across Arkansas, Louisiana, Oklahoma, and Texas. We specialize in the following sectors: – Aerospace & Aviation – Agricultural Machinery – Construction Machinery – Glasswork Machinery – Jewelry – Leather Machinery – Oil & Gas Equipment and Machinery – Textile Machinery – Woodworking Machinery For more information about our organization or to connect with any of the Italian companies we represent, please get in touch with us at: houston@ice.it +1 281-888-4288 https://itahouston.com/ | The Italian Trade Agency (ITA), ANFIA – the Italian Association of the Automotive Industry – and AICA, the Italian Garage Equipment Manufacturers Association, are proudly featured here. ITA is the government body driving the global expansion of Italian companies and attracting foreign investment into Italy, operating through a vast network of offices tied to embassies and consulates worldwide. ANFIA has championed Italy’s automotive sector for over a century, representing its members’ interests across technical, economic, and policy domains. AICA serves as the voice of Italy’s renowned garage equipment manufacturers, advocating nationally and internationally for innovation and excellence in the industry. | ITA – Italian Trade Agency is the Governmental agency that supports the business development of our companies abroad and promotes the attraction of foreign investment in Italy. Come visit us at the Italian Pavilion (booth 627) to see the latest in EV technology from the following technologies PODIUM ADVANCED TECHNOLOGIES,TECNA, MEVIS S.p.A., SPEA S.p.A., 2A S.p.A., SED srl, XEPICS, LOPIGOM S.p.A.
Inventage Lab Inc
.. | Inventage Lab(KOSDAQ: 389470) is a clinical-stage biopharmaceutical company specializing in drug delivery system, especially the development of long-acting injectables and lipid nanoparticles using a microfluidic manufacturing platform. IVL-DrugFluidic® platform enables the production of high-quality of microsphere based long-acting injectable formulations by eliminating initial drug over-release and ensuring the mass production of uniform microspheres. It has been successfully applied to veterinary medicine and clinical trials for androgenic alopecia, dementia, and addiction treatments. The platform also supports drug re-discovery and partnerships for novel drug formulations with partnering pharmaceutical companies. Harnessing our HANDYGENE™ system, this platform focuses on developing lipid nanoparticles (LNPs) for vaccines and gene therapies. Inventage Lab also offers services, including LNP formulation and non-clinical and clinical sample production, while diversifying its business through selling and subscribing to its LNP manufacturing equipment.
INTRAVACC
Intravacc is an established independent CDMO with years of experience in developing and optimizing vaccines for infectious diseases and therapeutic vaccines, which has transferred its technology worldwide for vaccines against polio, measles, diphtheria, Hib, and influenza. Around 30% of childhood disease vaccines are based on Intravacc’s technology and knowhow. Intravacc offers a wide range of expertise for independent vaccine development, from concept to Phase I/II clinical studies, for customers around the world. Intravacc continues to capitalize on the critical global trends in healthcare: the ever-growing need for prevention and intervention for infectious diseases and cancer. Our innovative vaccine platforms and vaccine contract development and manufacturing capabilities are well positioned to address the unmet needs in the vaccine and immune therapy market which is currently estimated at $37 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 6.6% to $55 billion by 2027. The company’s head office is located on the Utrecht Science Park location Bilthoven, The Netherlands, and has state-of-the-art laboratories and GMP production facilities. Intravacc B.V. is a limited liability company incorporated under Dutch law. Intravacc is a state holding company since 1 January 2021, under the Ministry of Health, Welfare and Sports (VWS). | . | Your specialized CDMO to accelerate the development of your viral, bacterial, therapeutic, and conjugate vaccines. From discovery to phase II clinical trial. Based in the Netherlands within the Utrecht Science Park in Bilthoven, Intravacc is a globally recognized pioneer and leader in translational vaccinology. With decades of experience, we stand as an independent Contract Development and Manufacturing Organization (CDMO) within the vaccine industry. Our purpose is to serve as the vital link between your discoveries and early-stage clinical trials of new vaccines. We understand that this journey from concept to GMP production is often riddled with challenges, and we specialize in mitigating risks and reducing costs. | Your specialized CDMO for viral, bacterial, therapeutic, and conjugate vaccines Based in the Netherlands and nestled within the Utrecht Science Park in Bilthoven, Intravacc is a globally recognized leader in translational vaccinology. With decades of experience, we stand as an independent Contract Development and Manufacturing Organization (CDMO) within the vaccine industry. Our purpose is to serve as the vital link between your discoveries and early-stage clinical trials. We understand that this journey from concept to GMP production is often riddled with challenges, and we specialize in mitigating risks and reducing costs. The entire team at Intravacc is committed to blazing new paths in vaccine development. We have an exceptional track record imagining and realizing technologies that enable tomorrow’s vaccines. That expertise in vaccine development is at the core of our CDMO services and candidate vaccines out-licensing.
Instituto de Terapia Celular
ITC CDMO is Latin America’s premier Contract Development and Manufacturing Organization, positioned at the forefront of the regenerative medicine industry. With over 16 years of expertise in pioneering stem cell-based treatments and exosome therapeutics, we deliver innovative, high-quality solutions, bridging groundbreaking research to commercial success. Our comprehensive business-to-business (B2B) services cater specifically to biotechnology companies, research institutions, and healthcare providers, covering every phase from early-stage research and process development to commercial manufacturing. We ensure precision, compliance, and technological excellence at every step. Our state-of-the-art facilities feature ISO 5-classified cleanroom environments, specialized cell-processing capabilities, and advanced exosome purification technologies. We employ strict Good Manufacturing Practices (GMP), exclusively utilizing GMP-grade reagents, ensuring product integrity, safety, and efficacy. Through our extensive network of licensed regenerative medicine hospitals, we facilitate rapid clinical adoption and streamline product commercialization, significantly reducing your time-to-market. Our dedicated pilot laboratories support smooth transitions from laboratory-scale to full-scale manufacturing, minimizing risks and optimizing scalability. At ITC CDMO, we prioritize strategic partnerships built on collaboration, transparency, and mutual success. Our multidisciplinary expert teams—comprising scientists, engineers, and regulatory specialists—work closely with partners to navigate complex development processes effectively. Committed to continuous innovation, we invest in ongoing R&D collaborations, ensuring access to cutting-edge technologies. Our ethical and sustainable practices further enhance our commitment to responsible innovation. Partner with ITC CDMO at global biotechnology events like BIO International Convention to accelerate your therapeutic innovations and achieve market leadership in regenerative medicine. Choose ITC CDMO—your strategic partner for success, compliance, and unmatched quality.